BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 23, 2019
View Archived Issues
Huntington's and astrocytes: no good guys, bad guys
Read More
Novel wogonin derivatives as potent and selective CDK9 inhibitors for leukemia treatment
Read More
Preclinical studies of gelonin-chlorotoxin fusion protein for targeted glioblastoma therapy
Read More
Viral m6A methylation upregulates RSV replication and pathogenesis, emerging as a potential target
Read More
Tricyclic resveratrol boosts blood stem cell transduction rates
Read More
[211At]Farletuzumab shows efficacy in a disseminated ovarian cancer mouse model
Read More
[68Ga]JMV-6659 shows promising for PET imaging of tumors expressing NTS1
Read More
KNG as a potential new biomarker during epileptogenesis
Read More
PD-340 alleviates behavioral deficits related to cognitive impairment in mouse model of AD
Read More
VBJ-192 and VBJ-215 show encouraging results without tolerance or locomotor side effects
Read More
Novel gamma-secretase inhibitor PIPE-505 restores synaptic function, regenerates outer hair cells
Read More
Cantabio Pharmaceuticals forms collaboration for drugs targeting DJ-1 protein
Read More
Mochida Pharmaceutical divulges muscarinic M3 receptor PAMs
Read More
Bicycle Therapeutics, Oxford Drug Discovery Institute to work on therapeutics for dementia
Read More
Blade Therapeutics identifies new calpain inhibitors
Read More
Hanlim Pharmaceutical presents new cathepsin K inhibitors
Read More
Grant supports clinical trial of personalized treatment approach for aplastic anemia
Read More
Response to treatment observed in phase Ib/II trial of onvansertib in KRAS-mutated colorectal cancer
Read More
Takeda Pharmaceutical patents ionotropic glutamate GluN2B receptor antagonists
Read More
BUGWORKS Research India synthesizes new antibacterials
Read More
Provention reports phase IIa topline results for PRV-6527 in moderate to severe Crohn's disease
Read More
Vast Therapeutics' BIOC-11 eradicates 99% of NTM in animal model
Read More
Washington University to study effects of Kaleido's Microbiome Metabolic Therapies
Read More
CheckMate-9LA study of Opdivo plus low-dose Yervoy in first-line NSCLC meets primary endpoint
Read More
Talaris begins phase III trial of FCR-001 in living donor kidney transplant recipients
Read More